Why RNA Vaccines for COVID-19 Raced to the Front of the Pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells. Developing and testing a new vaccine typically takes…
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells. Developing and testing a new vaccine typically takes…
A Rutgers philosopher examines the ethical questions around human challenge trials for COVID-19 vaccines. The first human challenge trial to test COVID-19 treatments and vaccines…
First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease,…
When will life return to normal, when will immunity kick in? As the Centers for Disease Control and Prevention (CDC) begins to schedule the vaccine…
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical…
Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against COVID-19 based on the yellow fever vaccine, which as a…
TB Vaccine Linked to Lower Risk of Contracting COVID-19 A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to…
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study published today (November 20, 2020) in mBio, an open-access…
Mutation is not expected to interfere with effectiveness of vaccines under development. A new study published in Science confirms that SARS-CoV-2 has mutated in a…
Similar to bacteria evolving resistance to antibiotics, viruses can evolve resistance to vaccines, and the evolution of SARS-CoV-2 could undermine the effectiveness of vaccines that…
Researchers at the University of Pittsburgh School of Medicine describe, in the journal Science, a new method to extract tiny but extremely powerful SARS-CoV-2 antibody…
MedUni Vienna study provides new information for a better understanding of the disease – and potential biomarkers for vaccine development. In a study recently published…
New study demonstrates candidate’s potential to generate antibodies, limit viral shedding. A genetically edited form of a herpes simplex virus — rewired to keep it…
Good uptake (8 out of 10 people) will likely be needed to achieve herd immunity through vaccination. Governments should consider incentivizing people to get a…
Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models. An innovative nanoparticle vaccine candidate for…
New info on antibody levels in sicker patients and elderly could inform vaccine goals. As vaccine trials progress and public health officials brace for a…
Changing the makeup of a specific protein has the potential to neutralize the virus. A University at Buffalo-led research team has discovered a technique that…
Two separate studies have documented the persistence of antibodies that target SARS-CoV-2 in hundreds of patients with COVID-19 at least 3 months after symptom onset….